Tonix Pharmaceuticals
TNXP
TNXP
22 hedge funds and large institutions have $3.63M invested in Tonix Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
Holders
22
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.75M | |
| 2 | +$349K | |
| 3 | +$65.5K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$46.5K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$26.3K |
Top Sellers
| 1 | -$274K | |
| 2 | -$267K | |
| 3 | -$123K | |
| 4 |
Millennium Management
New York
|
-$95K |
| 5 |
Two Sigma Investments
New York
|
-$74.4K |